Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2

The outbreaks of severe acute respiratory syndrome (SARS) and Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV and SARS-CoV-2, respectively, have posed severe threats to global public health and the economy. Treatment and prevention of these viral diseases call for the research and development...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Fei, Xiang, Rong, Deng, Xiaoqian, Wang, Lili, Yu, Zhengsen, Tian, Shijun, Liang, Ruiying, Li, Yanbai, Ying, Tianlei, Jiang, Shibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506210/
https://www.ncbi.nlm.nih.gov/pubmed/32963228
http://dx.doi.org/10.1038/s41392-020-00318-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506210/
https://www.ncbi.nlm.nih.gov/pubmed/32963228
http://dx.doi.org/10.1038/s41392-020-00318-0

Ejemplares similares